Orient Pharma Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 427.23 million compared to TWD 295.09 million a year ago. Net income was TWD 0.203 million compared to TWD 19.53 million a year ago.